Page last updated: 2024-08-26

mafosfamide and thiotepa

mafosfamide has been researched along with thiotepa in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balis, FM; Blaney, SM; Poplack, DG	1
Hansen, WK; Kelley, MR; Limp-Foster, M; Rosenquist, TA; Williams, DA; Xu, Y	1

Other Studies

2 other study(ies) available for mafosfamide and thiotepa

Article	Year
Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5 Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa	1991
Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3 Topics: 3T3 Cells; Animals; Antineoplastic Agents; Blotting, Northern; Carmustine; Cell Division; Cyclophosphamide; Cytoprotection; DNA; DNA Damage; DNA Repair; DNA-Formamidopyrimidine Glycosylase; Drug Interactions; Escherichia coli Proteins; Genetic Therapy; Genetic Vectors; Humans; Mice; N-Glycosyl Hydrolases; Thiotepa; Transfection; Transgenes	2001

Article

Year

Pharmacologic approaches to the treatment of meningeal malignancy.

Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5

Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa

1991

Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.

The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3

Topics: 3T3 Cells; Animals; Antineoplastic Agents; Blotting, Northern; Carmustine; Cell Division; Cyclophosphamide; Cytoprotection; DNA; DNA Damage; DNA Repair; DNA-Formamidopyrimidine Glycosylase; Drug Interactions; Escherichia coli Proteins; Genetic Therapy; Genetic Vectors; Humans; Mice; N-Glycosyl Hydrolases; Thiotepa; Transfection; Transgenes

2001